<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Paaske Head | Activity</title>
	<link>https://www.catswannabecats.com/members/oilsphynx9/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/oilsphynx9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Paaske Head.</description>
	<lastBuildDate>Wed, 01 Jul 2026 18:37:05 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3fadb4ad892129c9353d391761f18334</guid>
				<title>Paaske Head posted an update: 7% (365 ADR episodes in 199 patients). Of the AEs of special [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23317/</link>
				<pubDate>Sun, 08 Jun 2025 08:55:53 -0400</pubDate>

									<content:encoded><![CDATA[<p>7% (365 ADR episodes in 199 patients). Of the AEs of special interest, the most common were cerebral edema (22.2%, 124/558 patients), convulsion (9.9%, 55/558 patients), impaired healing (4.8%, 27/558 patients), and infection (3.4%, 19/558 patients). This first all-case postmarketing surveillance report of the safety of Gliadel in real-world&hellip;<span class="activity-read-more" id="activity-read-more-23317"><a href="https://www.catswannabecats.com/activity/p/23317/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">84256b80feac81853176ab6c6119fb44</guid>
				<title>Paaske Head posted an update: 05). Liver and kidney functions were influenced by in ovo [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17944/</link>
				<pubDate>Tue, 03 Jun 2025 12:23:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>05). Liver and kidney functions were influenced by in ovo AKP injections in broilers. Antioxidant enzymes also changed significantly after in ovo injection with AKP. Moreover, in ovo injection of AKP significantly altered immunity (IgG and IgM) in broilers. In conclusion, in ovo injection of AKP significantly improved liver and kidney functions,&hellip;<span class="activity-read-more" id="activity-read-more-17944"><a href="https://www.catswannabecats.com/activity/p/17944/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3de02002a9afcd88819dc56fa6a4ffcc</guid>
				<title>Paaske Head posted an update: For pituitary regenerative medicine, the creation of a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2002/</link>
				<pubDate>Sat, 31 May 2025 07:44:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>For pituitary regenerative medicine, the creation of a hypophyseal model in monkeys is necessary to conduct future preclinical studies; however, previous studies reported that hypophysectomy in monkeys is not always safe or satisfactory. This study aimed to create a hypophyseal dysfunction model in a cynomolgus monkey using a safer surgical&hellip;<span class="activity-read-more" id="activity-read-more-2002"><a href="https://www.catswannabecats.com/activity/p/2002/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">16397f997c3d79d06df602749d8b67f5</guid>
				<title>Paaske Head became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/1853/</link>
				<pubDate>Sat, 31 May 2025 07:36:17 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>